RE: shhhhhh4 May 2023 12:27
Aim is terrible. When on the release of good news, the initial rise disappears and the share price ends up down on the day. Then there never seems to be the volume to take the price back up. It deters any long term investing from those that are new to the aim market.
Ps! I think that hemo will go back up later due to news still due and the posible value of a clinical product. And for the brave the mms are giving the opportunity to buy at prices that ignore the news so far.